Theralase Technologies Inc. is on the rise, attracting investor interest with a notable gain in its stock price.
Theralase Technologies Inc. (TLT.V) is experiencing a positive shift in its stock performance, rising by 1.79% during today’s trading session. The company, which focuses on innovative medical technologies, is currently valued at approximately CA$0.28 per share.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Theralase Technologies Inc.
TLT.V
TLT.V
Theralase Technologies Inc.
WealthAwesomeMarket cap
$84.27M
52W high
$0.41
52W low
$0.15
1W change
+7.55%
Beta
0.59
Analyst Price Targets
Based on analyst covering TLT
Wall Street analysts forecast TLT stock price to rise 145.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+145.6% Upside
Current Price
C$0.28
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TLT's historical volatility
30-Day Vol
47.9%
Annualized
90-Day Vol
94.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.34
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.30 | C$0.26 – C$0.36 |
| 60 trading days | C$0.32 | C$0.25 – C$0.41 |
| 90 trading days | C$0.34 | C$0.26 – C$0.45 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors may see Theralase's recent gains as a sign of growing confidence in its business model and future prospects, particularly after its recent financial disclosures.
Theralase Technologies Inc. Gains 1.79% Today
The stock's current market cap stands at CA$84.27 million, reflecting its potential for growth in the medical technology sector.
Bull case
The company has shown strong performance with a recent revenue increase and a significant reduction in net loss. These improvements suggest a potential turnaround that could attract more investors.
Bear case
Despite today’s positive movement, Theralase's stock still has its challenges. The lack of dividends and a history of volatility may make some risk-averse investors hesitant to jump in.
Advertisement
Recent Performance Overview
Theralase Technologies Inc. is gaining today, with its stock price climbing 1.79%. This positive movement comes amid a backdrop of increased investor interest, particularly following the release of its Q1 2026 financial statements, which highlighted a 45% revenue increase.
Market Sentiment and Future Outlook
The market's reception of Theralase's recent financial disclosures suggests a growing confidence in its business model. Investors are particularly optimistic about the company's ongoing projects and its potential for future growth, especially in the medical technology sector. However, the absence of dividends may still deter some investors from fully committing to the stock.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
